DNA-variationer ved multipel sklerose 

Vi fandt, at der ikke var signifikant sammenhæng mellem MS og mtDNA-variationerne G15927A eller G15928A. Det tidligere studie med 100 tyske MS-patienter viste, at mtDNA-variationerne G15927A eller G15928A forekom hos 14% af alle MS-patienterne og hos 2% af kontrolpersonerne.6 Således har de to studier modstridende resultater.

Hear the latest data on the association between smoking and an increased risk of MS. There are several interesting new data.

Sporadic cases of fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. In this MEDtalk Trygve Holmøy present a study based on European Medicines Agency database of suspected adverse reactions related to medicinal products in the European Economic Area (EudraVigilance), for fatal adverse events associated with treatment with alemtuzumab. Trygve Holmøy and colleagues identified nine cases with a probable and one case with a possible causal relationship between alemtuzumab treatment and a fatal adverse event.

MEST SETE MEDtalks

ECTRIMS 2018: Klinisk betydning af neurofilament som biomarkør   Se hele webinar

ECTRIMS 2018: Klinisk betydning af neurofilament som biomarkør

<img width="600" height="360" src="https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-600x360.jpg" class="attachment-category_newDes_thumb_1 size-category_newDes_thumb_1 wp-post-image" alt="" srcset="https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-600x360.jpg 600w, https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-300x179.jpg 300w, https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-768x459.jpg 768w, https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-1024x612.jpg 1024w, https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018-360x215.jpg 360w, https://bestprac.dk/wp-content/uploads/2018/10/bp_zsolt-laszlo-illes1_ectrims_berlin_2018.jpg 1200w" sizes="(max-width: 600px) 100vw, 600px" />
ECTRIMS 2018: Klinisk betydning af neurofilament som biomarkør&nbsp;&nbsp;&nbsp;<a href='https://bestprac.dk/webinar/ectrims-2018-klinisk-betydning-af-neurofilament-som-biomarkoer/'>Se hele webinar
Klinisk betydning af neurofilament som biomarkør

ECTRIMS 2018: God kandidat til førstevalg ved recidiverende-remitterende MS

<script src="https://fast.wistia.com/embed/medias/p4mrjugra3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_p4mrjugra3 seo=false videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/p4mrjugra3/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
ECTRIMS 2018: God kandidat til førstevalg ved recidiverende-remitterende MS&nbsp;&nbsp;&nbsp;<a href='https://bestprac.dk/webinar/ectrims-2018-god-kandidat-til-foerstevalg-ved/'>Se hele webinar
God kandidat til førstevalg ved recidiverende-remitterende MS

ECTRIMS 2018: Opsigtsvækkende langtidsdata for behandling med alemtuzumab

<img width="600" height="360" src="https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-600x360.jpg" class="attachment-category_newDes_thumb_1 size-category_newDes_thumb_1 wp-post-image" alt="" srcset="https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-600x360.jpg 600w, https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-300x179.jpg 300w, https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-768x459.jpg 768w, https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-1024x612.jpg 1024w, https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer-360x215.jpg 360w, https://bestprac.dk/wp-content/uploads/2018/10/barry-a-singer.jpg 1200w" sizes="(max-width: 600px) 100vw, 600px" />
ECTRIMS 2018: Opsigtsvækkende langtidsdata for behandling med alemtuzumab&nbsp;&nbsp;&nbsp;<a href='https://bestprac.dk/webinar/ectrims-2018-opsigtsvaekkende-langtidsdata-for-behandling-med-alemtuzumab/'>Se hele webinar
Opsigtsvækkende langtidsdata for behandling med alemtuzumab

ECTRIMS 2018: Tecfidera reducerer signifikant neurofilament-niveauet

<img width="600" height="360" src="https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-600x360.png" class="attachment-category_newDes_thumb_1 size-category_newDes_thumb_1 wp-post-image" alt="" srcset="https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-600x360.png 600w, https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-300x179.png 300w, https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-768x459.png 768w, https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-1024x612.png 1024w, https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap-360x215.png 360w, https://bestprac.dk/wp-content/uploads/2018/10/tobias-playknap.png 1200w" sizes="(max-width: 600px) 100vw, 600px" />
ECTRIMS 2018: Tecfidera reducerer signifikant neurofilament-niveauet&nbsp;&nbsp;&nbsp;<a href='https://bestprac.dk/webinar/ectrims-2018-tecfidera-reducerer-signifikant-neurofilament-niveauet/'>Se hele webinar
Tecfidera reducerer signifikant neurofilament-niveauet

Highlights from ECTRIMS

Melinda Magyari, Head of the Danish MS Registry, gives in this MEdtalk some of her highlights from the ECTRIMS Congress.

A larger decrease in total costs was observed in patients with MS who received their first disease modifying therapies early, which could potentially be explained by a slower disease progression leading to maintained work capacity.

Galina Zheleznyakova have dentified a number of different sncRNAs where further research may pave the way for identification of informative biomarkers and possible treatment targets. In this MEdtalk she present the result from the study.

#Seneste udgivelse

Psykiatri / Neurologi

Nr. 45 • maj 2019
12. Årgang
  • Multipel sclerose
  • Vedvarende sorglidelse
  • Eksekutive funktioner

ECTRIMS 2019